Wendy Seiferheld

Wendy Seiferheld

UNVERIFIED PROFILE

Are you Wendy Seiferheld?   Register this Author

Register author
Wendy Seiferheld

Wendy Seiferheld

Publications by authors named "Wendy Seiferheld"

Are you Wendy Seiferheld?   Register this Author

13Publications

170Reads

24Profile Views

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

N Engl J Med 2017 02;376(5):417-428

From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444881PMC
February 2017

Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.

Int J Radiat Oncol Biol Phys 2007 Nov 8;69(3):831-8. Epub 2007 Jun 8.

Department of Radiation Oncology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095-6951, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.04.017DOI Listing
November 2007

Imaging response in malignant glioma, RTOG 90-06.

Am J Clin Oncol 2007 Feb;30(1):32-7

Hospital of the University of Pennsylvania, Department of Radiation Oncology, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000236214.13206.38DOI Listing
February 2007

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.

J Neurooncol 2005 Sep;74(2):201-5

Department of Radiation Oncology, London Regional Cancer Program and University of Western Ontario, 790 Commissioners Road East, London N6A 4L6, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-004-6596-9DOI Listing
September 2005